From: 23/06/2016 to: 23/06/2016 ESO Recommended Session on Lung Cancer, St. Petersburg, Russian Federation                                        From: 24/06/2016 to: 26/06/2016 2nd Masterclass in Cancer Patient Advocacy, Milan, Italy                                        From: 29/06/2016 to: 29/06/2016 13th ESO Colorectal Cancer Observatory, Barcelona, Spain                                        From: 04/07/2016 to: 05/07/2016 ESMO Preceptorship on Immuno-Oncology 2016, Siena, Italy                                        From: 14/07/2016 to: 19/07/2016 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 29/08/2016 to: 09/09/2016 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Poznan, Poland                                        From: 15/09/2016 to: 16/09/2016 Eastern Europe and Balkan Region Refresher Course on Gastro-intestinal Cancer, Budapest, Hungary                                        From: 15/09/2016 to: 17/09/2016 ESO-EANO Masterclass in Neuro-Oncology: A Challenges in Radiotherapy for Patients with Gliomas, Lugano, Switzerland                                        From: 30/09/2016 to: 01/10/2016 ESMO Preceptorship on Immuno-Oncology 2016, Amsterdam, The Netherlands                                        From: 19/10/2016 to: 19/10/2016 Multidisciplinary Care in Prostate Cancer Units: A European Guidelines and Beyond, Dublin, Ireland                                        From: 28/10/2016 to: 30/10/2016 5th ESO Arab Countries Masterclass in Clinical Oncology, Cairo, Egypt                                        From: 02/11/2016 to: 03/11/2016 ESMO Preceptorship on Immuno-Oncology 2016, Zurich, Switzerland                                        From: 10/11/2016 to: 12/11/2016 3rd ESO-ESMO Breast Cancer in Young Women International Conference, Lugano, Switzerland                                        From: 23/11/2016 to: 24/11/2016 ESO Course on Gynecological and Urogenital Tumours, Tbilisi, Georgia                                        From: 18/11/2016 to: 19/11/2016 ESNM-ESO Learning Course on 18FDG PET-CT in Lymphoma, Vienna, Austria                                        From: 19/11/2016 to: 23/11/2016 4th ESO-ESTRO Masterclass in Radiation Oncology, Prague, Czech Republic                                        From: 23/11/2016 to: 24/11/2016 ESO-TUM-IAS Masterclass in Ethical Counselling in Oncology and Gender Issues, Munich, Germany                                        From: 25/11/2016 to: 26/11/2016 Molecular Diagnostics, Genomics and Epigenetics in Clinical Oncology, Rome, Italy                                        From: 25/11/2016 to: 27/11/2016 Clinical Update on Rare Adult Solid Cancers, Milan, Italy                                        From: 09/11/2016 to: 10/11/2016 ESMO Preceptorship on Immuno-Oncology 2016, Madrid, Spain

Industry Support


As an independent, non-profit organisation which has the mission to decrease cancer deaths due to lack of knowledge, the European School of Oncology (ESO) is committed to working with all stakeholder groups to try to improve cancer outcomes. The School recognises that different industries make an important contribution to improving cancer outcomes through the development of innovative technologies including diagnostics, imaging, surgical  and radiotherapy equipment, and medicines. For this reason ESO fosters on-going dialogue and collaboration with industry partners.  

In July 2004 ESO established the Sharing Progress in Cancer Care (SPCC) programme in order to facilitate its interactions with industry partners. SPCC partners are required to make an annual unrestricted donation to the School. Donations from SPCC partners are pooled and used to support a number of ESO initiatives including the Masterclass in Clinical Oncology, Cancer World magazine and free or low-fee educational events. Many of these events are held in low- to middle-income countries, which are not well served by other providers of cancer education. In addition, ESO gives SPCC partners  the opportunity to propose collaborative projects, which are only accepted if they are aligned with ESO's mission, have multi-sponsors and address a clear unmet educational need.   

The School maintains total editorial control over the planning and execution of all ESO projects. SPCC partners may be invited to contribute ideas, as appropriate, but decisions about procedures and content are made by ESO.

Donations from SPCC partners represent no more than 25% of ESO's annual budget. The rest of ESO's funding comes from its two sustaining foundations, royalties, income from conferences and donations from individual supporters.

The companies that are currently member of the SPCC programme are:

           

 Bayer      
 Merck KGaA, Darmstadt, Germany
 Boehringer Ingelheim      
 Novartis
 Bristol-Myers Squibb       Pfizer
 Celgene Corporation      
 Roche
 Genomic Health       Sandoz Biopharmaceutical
 Helsinn      Sanofi Oncology
 Lilly        


Sharing Progress in Cancer Care
Department Coordinator

Matti Aapro, Geneva

For further information please contact Daniela Mengato at dmengato@eso.net